Improving seated balance for wheelchair users with spinal cord injuries using an exoskeleton

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the effects of exoskeleton-assisted walking (EAW) on seated balance in individuals with spinal cord injuries (SCI) who are wheelchair users. Participants will undergo 36 sessions of EAW training, which aims to enhance trunk muscle use and improve overall seated stability and independence in daily activities. The study will measure primary outcomes related to seated balance and secondary outcomes concerning body composition. The research is conducted at the James J. Peters Veterans Affairs Medical Center in Bronx, New York.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Traumatic or non-traumatic SCI ≥6 months duration of SCI;
2. Wheelchair-user for indoor and outdoor mobility;
3. Level and completeness of injury T4 and below with complete or incomplete SCI (ISNCSCI A to D);
4. Able to hold the crutches in hands with or without modifications; and
5. Able to provide informed consent.

Exclusion Criteria:

1. Diagnosis of neurological injury other than SCI;
2. Progressive condition that would be expected to result in changing neurological status;
3. Severe concurrent medical disease, illness or condition judged to be contraindicated by the Site Physician;
4. Anthropocentric incompatibility to be fitted with the device;
5. Traumatic or high impact lower extremity fracture within the past 2 years;
6. Fragility, minimal trauma or low impact fracture of the lower extremity since spinal cord injury;
7. Knee BMD \< 0.60 gm/cm2;
8. Total hip BMD T-scores \< -3.5;
9. Untreatable severe spasticity judged to be contraindicated by the Site Physician;
10. Flexion contracture that is incompatible with the device;
11. Limitations in ankle range of motion that cannot be adapted with an orthotic device (plantar flexion \> 00);
12. Fracture of the foot by x-ray and confirmed by CT;
13. Untreated or uncontrolled hypertension (systolic blood pressure \>140 mmHg; diastolic blood pressure \>90 mmHg);
14. Unresolved orthostatic hypotension (systolic blood pressure \<90 mmHg; diastolic blood pressure \<60 mmHg) as judged to be contraindicated by the Site Physician;
15. Current pressure ulcer of the arms, trunk, pelvic area, or lower extremities;
16. History of seizure;
17. Use of medications that significantly lower seizure threshold, such as tricyclic antidepressants, amphetamines, neuroleptics, dalfampridine, and bupropion;
18. History of stroke, brain tumor, brain abscess, or multiple sclerosis;
19. History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging);
20. History of implanted brain/spine/nerve simulators, aneurysm clips, ferromagnetic metallic implants, or cardiac pacemaker/defibrillator;
21. Psychopathology documentation in the medical record or history that may conflict with study objectives; and/or
22. Pregnancy or women who plan to become pregnant during the study period.

Where it's running

• James J. Peters VA Medical Center
  The Bronx, New York, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury

  This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.

  Recruiting TryAbility LLC · Downers Grove, Illinois · NCT07922122

• NG004 for incomplete cervical spinal cord injury

  This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.

  Recruiting at 7 sites Phase 1 NovaGo Therapeutics AG · Bayreuth and 9 other locations · NCT07840196

• Robot-assisted training for arm and leg movement after stroke or injury

  This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.

  Recruiting Bangladesh Medical University · Dhaka · NCT07749625

• ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab

  This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.

  Recruiting Bangladesh Medical University · Dhaka, Dhaka Division · NCT07705906

• Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury

  This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.

  Recruiting Shengjing Hospital · Shenyang · NCT07704268

• Hybrid HIIT-FES cycling program for people with spinal cord injury

  This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.

  Recruiting William Carey University · Hattiesburg, Mississippi · NCT07648173

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.